We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$36.7M
1-Year Est. Return
6.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.53%
1 Year Est. Return
-6.81%
3 Year Est. Return
-2.78%
5 Year Est. Return
-4.97%
10 Year Est. Return
+711.77%
AUM
$74.3M
AUM Growth
-$19.5M
(-21%)
Cap. Flow
+$3.58M
Cap. Flow
% of AUM
4.82%
Top 10 Holdings %
Top 10 Hldgs %
40.97%
Holding
64
New
3
Increased
22
Reduced
12
Closed
5
Top Buys
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$2.29M |
| 2 |
QuinStreet
QNST
|
+$1.23M |
| 3 |
Asure Software
ASUR
|
+$873K |
| 4 |
Regenxbio
RGNX
|
+$625K |
| 5 |
Digital Turbine
APPS
|
+$618K |
Top Sells
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$963K |
| 2 |
VRTU
Virtusa Corporation
VRTU
|
+$816K |
| 3 |
Carnival Corporation Ltd
CCL
|
+$762K |
| 4 |
New Mountain Finance
NMFC
|
+$550K |
| 5 |
APTO
Aptose Biosciences, Inc.
APTO
|
+$531K |
Sector Composition
| 1 | Technology | 28.41% |
| 2 | Healthcare | 27.96% |
| 3 | Communication Services | 14.78% |
| 4 | Consumer Staples | 10.92% |
| 5 | Financials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APTO
1
DELISTED
Aptose Biosciences, Inc.
APTO
| $3.56M | 4.8% |
1,333
-178
| -12% | -$531K |
|
2
Allot
ALLT
$408M
| $3.54M | 4.77% |
375,000
-25,000
| -6% | -$250K |
|
|
CNST
3
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $3.3M | 4.44% |
105,000
-5,000
| -5% | -$174K |
|
4
CareCloud
CCLD
$99M
| $3.27M | 4.41% |
595,000
| – | – |
|
|
5
Digital Turbine
APPS
$1.04B
| $3.23M | 4.35% |
750,000
+100,000
| +15% | +$618K |
|
6
Chegg
CHGG
$87.3M
| $2.86M | 3.85% |
80,000
+5,000
| +7% | +$195K |
|
|
CTLP
7
DELISTED
Cantaloupe
CTLP
| $2.76M | 3.72% |
600,000
+50,000
| +9% | +$230K |
|
8
OptimizeRx
OPRX
$125M
| $2.72M | 3.66% |
300,000
+15,000
| +5% | +$142K |
|
9
Mitek Systems
MITK
$869M
| $2.68M | 3.61% |
340,000
-60,000
| -15% | -$510K |
|
|
RCM
10
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.5M | 3.37% |
275,000
-25,000
| -8% | -$301K |
|
|
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.45M | 3.3% |
12,000
+7,200
| +150% | +$2.29M |
|
12
Gaia
GAIA
$52.1M
| $2.44M | 3.29% |
275,000
| – | – |
|
13
Ambarella
AMBA
$2.78B
| $2.43M | 3.27% |
50,000
+10,000
| +25% | +$574K |
|
14
uniQure
QURE
$2.71B
| $2.37M | 3.19% |
50,000
+10,000
| +25% | +$575K |
|
|
VRTU
15
DELISTED
Virtusa Corporation
VRTU
| $2.27M | 3.06% |
80,000
-20,000
| -20% | -$816K |
|
16
Magnite
MGNI
$2.85B
| $2.22M | 2.99% |
400,000
+50,000
| +14% | +$460K |
|
|
ASPU
17
DELISTED
ASPEN GROUP, INC.
ASPU
| $2M | 2.69% |
250,000
-50,000
| -17% | -$419K |
|
18
EverQuote
EVER
$934M
| $1.97M | 2.65% |
75,000
| – | – |
|
|
19
Regenxbio
RGNX
$579M
| $1.62M | 2.18% |
50,000
+15,000
| +43% | +$625K |
|
20
Marchex
MCHX
$82M
| $1.3M | 1.76% |
900,000
+50,000
| +6% | +$144K |
|
|
EMKR
21
DELISTED
Emcore Corp
EMKR
| $1.3M | 1.75% |
58,000
| – | – |
|
22
Varonis Systems
VRNS
$5.4B
| $1.27M | 1.71% |
60,000
| – | – |
|
23
Microsoft
MSFT
$2.98T
| $946K | 1.27% |
6,000
| – | – |
|
|
IMDX
24
Insight Molecular Diagnostics
IMDX
$152M
| $858K | 1.16% |
17,500
+5,000
| +40% | +$245K |
|
|
QUOT
25
DELISTED
Quotient Technology Inc
QUOT
| $845K | 1.14% |
130,000
-20,000
| -13% | -$179K |
|
Similar funds
ICP
RH
CI
GC
FC
CM
BAM
AP
P.A.W. Capital's Q1 2020 Portfolio in Review
As of Q1 2020, P.A.W. Capital held 64 positions worth $74.3M, down 21% from $93.8M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
P.A.W. Capital deployed $3.58M of net new capital in Q1 2020, opening 3 new positions and adding to 22 existing holdings. Its largest new stake was QuinStreet: 100,000 shares worth $805K.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Virtusa Corporation, an estimated $816K trimmed.
- P.A.W. Capital's largest Q1 2020 buy was QuinStreet: 100,000 shares worth $805K.
- P.A.W. Capital added most to Eiger BioPharmaceuticals, Inc. in Q1 2020, an estimated $2.29M increase.
- P.A.W. Capital's biggest Q1 2020 reduction was Virtusa Corporation, cutting an estimated $816K.
- P.A.W. Capital fully exited Orchard Therapeutics plc American Depositary Shares in Q1 2020, selling an estimated $963K.
- P.A.W. Capital's ten largest holdings make up 41% of its $74.3M portfolio in Q1 2020.
- P.A.W. Capital opened 3 new positions and closed 5 in Q1 2020.
- P.A.W. Capital's portfolio value fell 21% quarter-over-quarter to $74.3M.
Based on P.A.W. Capital's 13F filing for Q1 2020, filed 8 May 2020.